387510622 | LVSMH | 15861687 | | 5394984 | 9/16/2006 12:00:00 AM | transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy | | DIS | Admission Date : 3/30/2006 Report Status : Discharge Date : 2/2/2006 ****** FINAL DISCHARGE ORDERS ****** FLEITMAN , BENNETT V 373-63-33-4 V10 Room : Te Tarage A Cam Seymasa , Indiana 06498 Service : MED DISCHARGE PATIENT ON : 1/18/06 AT 02:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY : YES Attending : CAFARO , ADALBERTO E. , M.D. CODE STATUS : Full code DISPOSITION : Rehabilitation DISCHARGE MEDICATIONS : ENTERIC COATED ASPIRIN -LRB- BABY -RRB- -LRB- ASPIRIN ENTERI ... -RRB- 162 MG PO DAILY LIPITOR -LRB- ATORVASTATIN -RRB- 10 MG PO DAILY Alert overridden : Override added on 1/18/06 by : POTENTIALLY SERIOUS INTERACTION : NIACIN , VIT . 
B-3 & ATORVASTATIN CALCIUM Reason for override : md aware CALCIUM CARBONATE -LRB- 500 MG ELEMENTAL CA + + -RRB- 500 MG PO TID NEXIUM -LRB- ESOMEPRAZOLE -RRB- 20 MG PO DAILY HYDROCHLOROTHIAZIDE 25 MG PO DAILY INSULIN 70/30 HUMAN 20 UNITS SC QAM AVAPRO -LRB- IRBESARTAN -RRB- 150 MG PO DAILY Alert overridden : Override added on 7/6/06 by : POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN Reason for override : md Previous Alert overridden Override added on 7/6/06 by : POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN Reason for override : aware Previous Alert overridden Override added on 10/30/06 by ENCE , TY R. , M.D. POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & IRBESARTAN Reason for override : aware Previous override reason : Override added on 10/30/06 by ELWONGER , JOHNNY T. , M.D. on order for POTASSIUM CHLORIDE IMMED . 
REL . 
PO -LRB- ref # 665886938 -RRB- POTENTIALLY SERIOUS INTERACTION : IRBESARTAN & POTASSIUM CHLORIDE Reason for override : md aware Previous override information : Override added on 10/30/06 by RUBIANO , NUMBERS D. , M.D. on order for POTASSIUM CHLORIDE IV -LRB- ref # 765178698 -RRB- POTENTIALLY SERIOUS INTERACTION : IRBESARTAN & POTASSIUM CHLORIDE Reason for override : md aware LEVAQUIN -LRB- LEVOFLOXACIN -RRB- 500 MG PO Q48H Food/Drug Interaction Instruction Administer iron products a minimum of 2 hours before or after a levofloxacin or ciprofloxacin dose dose If on tube feeds , please cycle -LRB- hold 1 hr before to 2 hr after -RRB- Take 2 hours before or 2 hours after dairy products . 
LOPRESSOR -LRB- METOPROLOL TARTRATE -RRB- 50 MG PO TID Starting Today -LRB- 10/24 -RRB- HOLD IF : HR < 55 OR SBP < 110 Food/Drug Interaction Instruction Take consistently with meals or on empty stomach . 
PILOCARPINE 0.5 % 2 DROP OS QID Starting Today -LRB- 10/24 -RRB- MULTIVITAMIN THERAPEUTIC -LRB- THERAPEUTIC MULTIVI ... -RRB- 1 TAB PO DAILY VITAMIN E -LRB- TOCOPHEROL-DL-ALPHA -RRB- 400 UNITS PO DAILY ALPHAGAN -LRB- BRIMONIDINE TARTRATE -RRB- 1 DROP OU BID XALATAN -LRB- LATANOPROST -RRB- 1 DROP OU QPM DIET : House / Low chol/low sat . 
fat ACTIVITY : Walking as tolerated FOLLOW UP APPOINTMENT -LRB- S -RRB- : PCP as scheduled on 4/11 1:30 , Stent removal Dr Menietto 7/20 1:30 endoscopy , GI Dr Scroggin 8/10 9am , ALLERGY : NKA ADMIT DIAGNOSIS : abdominal pain PRINCIPAL DISCHARGE DIAGNOSIS ; Responsible After Study for Causing Admission -RRB- transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy OTHER DIAGNOSIS ; Conditions , Infections , Complications , affecting Treatment/Stay DM , HTN , Esophageal Ca , glaucoma , PPM OPERATIONS AND PROCEDURES : OTHER TREATMENTS/PROCEDURES -LRB- NOT IN O.R. -RRB- s/p ercp stenting and sphinterotomy on 9/17/06 BRIEF RESUME OF HOSPITAL COURSE : CC : Abd Pain / GNR bacteremia *** HPI : 88F w DM , HTN , s/p PPM , h/o esoph CA s/p resxn p/w acute onset diffuse abd pain , somewhat stronger in LLQ , sharp , a/w nausea . 
Pain worse with eating . 
Had loose BMs x 3-4 days , no fevers , some chills . 
No CP , no palps , chronic stable DOE . 
In ED , Abd CT , U/S , HIDA scan all unremarkble , but 2/4 BCx with GNRs , and was given Levo/Flagyl . 
*** PMH : DM , HTN , TIA/CVA , s/p esoph CA s/p resection , s/p PPM *** ALL : NKDA *** HOME MEDS : Lipitor 10 , Vit E 400 , Pilocarpine , Timolol , Insulin 70/30 20 QAM , HCTZ 25 , PPI , Lopressor 50 bid , Avapro , ASA *** PEx : T96 .9 P56 140/46 Sats ok on RA . 
NAD . 
Lungs clear , RRR S1/S2 . 
Abd S/ND . 
Very mild tenderness , somewhat localized over LLQ . 
Hyperactive BS . 
Ext WWP . 
NONTOXIC looking . 
*** STUDIES : Abd CT : GB wall thickening , dilatation of pancreatic duct . 
HIDA : neg for CBD dist RUQ U/S : GB sludge *** NOTABLE LABS : AST 1425 , ALT 1259 , AlkPhos 198 , TB 1.9 , Amy 90 . 
Chem 7 / CBC unremarkable . 
No anion gap . 
BCx with 2/4 GNRs . 
*** A/P : 88F w abd pain of unclear etiology on admission with transaminitis , abd pain and suspected bile duct stones and sludge . 
Underwent ERCP which demonstrated dilated main pancreatitic duct s/p stenting , dilated CBD with sludge s/p sphinterectomy . 
Transaminitis and abd pain have continued to improve . 
*** ID : Given GNR bacteremia , emperically covered with Levo / Ceftaz . 
Cx grew pansensitive Kleb , and coverage was narrowed to Levo to complete a 14 day course . 
Surveillance cx negative . 
GI : Marked transaminitis . 
No recent new meds . 
Hepatitis serologies negative , U/S w Doppler to r/o Budd-Chiari esp given acute onset negative , Lactate + guaiac for ? 
mesenteric ischemia -LRB- but no gap -RRB- negative . 
No indication for surgery . 
GI consulted recommended ERC , results as above . 
LFTs trending down s/p sphinterotomy and ERCP . 
Will f/u with GI in 2 weeks for repeat ERCP at OEDMC . 
CV : Cont Lipitor , HCTZ , Lopressor , Avapro , ASA . 
No signs of ischemia , failure . 
Uptitrated avapro given persistent HTN , appears to be near maximally BB in terms of heart rate OPHTH : Cont eye drops ENDO : h/o DM , cont insulin + scale . 
FEN : Npo pending ercp , adv to clears s/p procedure well tolerated , K/Mg scales . 
Ppx : Nexium / Lovenox Full Code ADDITIONAL COMMENTS : DISCHARGE CONDITION : Stable TO DO/PLAN : * f/u with PCP and Gi as scheduled * return to ED with worsening symptoms of abd pain or if unable to tolera No dictated summary ENTERED BY : SALEH , ZACK D. , M.D. -LRB- NM201 -RRB- 1/18/06 @ 02 ****** END OF DISCHARGE ORDERS ****** 
